Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.
about
Genetically engineered Newcastle disease virus for malignant melanoma therapyEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsVoriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipientsCurcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progressionEfficacy of an Intervention to Alter Skin Cancer Risk Behaviors in Young Adults.Development of an Internet Intervention to Address Behaviors Associated with Skin Cancer Risk among Young AdultsSurgery of primary melanomas.Genetic analysis of melanocortin 1 receptor red hair color variants in a Russian population of Eastern Siberia.Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cellsInfiltrative T regulatory cells in enucleated uveal melanomas.A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study.Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth.Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.Similar nucleotide excision repair capacity in melanocytes and melanoma cellsEpigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesMelanoma incidence rates among whites in the U.S. MilitaryDesmoplastic melanoma presenting as pyogenic granuloma: report of a case with review of literature.Histamine receptors and cancer pharmacology.Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents.Human endogenous retroviruses and cancer prevention: evidence and prospectsCharacterization of tumor progression in engineered tissue using infrared spectroscopic imaging.Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.Sex disparities in cancer incidence by period and age.Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.Melanoma: Molecular Pathogenesis and Therapeutic ManagementPrognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.Racial differences in six major subtypes of melanoma: descriptive epidemiology.Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanomaClinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported CasesEffect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cellsDeep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targetsCellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of miceInflammatory Bowel Disease and Skin Cancer: An Assessment of Patient Risk Factors, Knowledge, and Skin Practices.Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care.
P2860
Q24597831-2431FD13-ABB5-4A74-B216-CC1D5C14A121Q26799046-80EBE32F-6320-47D0-8820-0C1073101DD7Q27012442-0D444235-C347-432A-BE73-C361CD6F31DBQ28543853-A8920554-3E84-4E5E-AFED-082279EA9ECAQ30277671-35C4A6AB-A662-4C64-B606-78DBEA863375Q30277956-DB64139F-A931-4B2A-8335-B1BB01A1966CQ30356095-96FCB7F8-CD34-42D2-9447-0C8E4F2491C4Q30490209-B7CD4ECF-5D4B-41A0-BA3D-82A34485C90EQ33408109-A9F1D13E-ECB8-4C92-8A17-A7EB05307A33Q33533679-2505022E-EC6E-432C-A30F-7309ED87B61FQ33610434-729337FB-BD0D-42CB-AC9D-E8D94FF2D521Q33623491-95906C01-7B0C-4D34-A5DC-436B763BD81BQ33637973-0252C511-2523-46D2-965A-F10268F7BAECQ33708801-90F27168-996E-4C5D-BE11-9EF9B024FD62Q33713264-FA93757A-828F-426A-9A0E-716D2014F01AQ33889751-83E40670-1781-4EE8-95F4-EABDBEA770E1Q33936972-5E53080C-5216-40A8-B42F-CBE0F3FBC2EDQ33980682-8686F21F-186B-4790-AD13-72525BECAACDQ34107520-8B053A36-4266-4E42-A0BC-1C882796C1E1Q34250415-800971A5-49B9-4056-B738-FB6910E6070DQ34356076-750F0523-9331-446C-9204-F690FAEA725CQ34520444-30E70950-B963-45CF-90DA-5AD4F0837470Q34530623-833F1EDA-2B5D-4BAE-A5F9-BC7CA9E734D0Q34539840-4118E293-5518-4D3B-8568-74262411E47AQ34611491-B8F85620-B389-488A-863C-696D1F54B28AQ34964129-A941A323-FE65-4550-ACB6-1D3DEB1594F4Q34976858-0D243620-77B4-4B94-891E-7DDDC8527BF3Q34980366-70044AC2-4EC1-418A-9F5D-E00CDB6E5DBAQ35137163-58595BC6-2619-4197-8F36-E7D1A272312EQ35324807-03995F2F-4CF1-4A14-AC4E-C46F48A9D424Q35535167-0A9DA19C-221B-4E96-88C9-60C8B0BD5D43Q35803185-7778EAFD-A375-4875-84E9-0F5CEE9F7EF8Q36117403-2748BA9F-B04D-4894-AF4F-6EA390E64CEFQ36179649-23673D20-AB26-47A2-8563-9F99BAE4FA6CQ36197056-C50C7FD2-C695-4CC4-8A6E-E1C45D5B68E4Q36255034-C7802AA5-E425-46FE-B18F-FDC27DFEA7A0Q36270042-1664C07A-5DCF-41C5-814D-BE4B24ECCECCQ36485270-9950B9C0-6F3A-4ECD-ACF6-1F8512A1E7A3Q36681110-68EC2B6A-38C5-4881-890D-B7EF09AD6A2CQ36691476-04E8895F-EF8A-49D6-BC5C-2B5C46B65299
P2860
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@ast
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@en
type
label
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@ast
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@en
prefLabel
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@ast
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@en
P2093
P356
P1476
Malignant melanoma in the 21st ...... ng, prevention, and diagnosis.
@en
P2093
Aditya Bardia
Barbara A Pockaj
Edward T Creagan
J Douglas Cameron
Jennifer L Hand
Jose S Pulido
Lisa A Kottschade
Lori A Erickson
Mark R Pittelkow
Melanoma Study Group of the Mayo Clinic Cancer Center
P304
P356
10.4065/82.3.364
P407
P577
2007-03-01T00:00:00Z